No Data
No Data
Stoke Therapeutics Launches Public Offering for Clinical Development
Express News | Stoke Therapeutics Shares Are Trading Lower After the Company Announced the Pricing of an Upsized $125 Million Public Offering of 5,555,557 Common Shares at $13.50 per Share
Sector Update: Health Care Stocks Advance Premarket Thursday
Health care stocks were advancing premarket Thursday, with the Health Care Select Sector SPDR Fund (XLV) up 0.1% and the iShares Biotechnology ETF (IBB) recently 0.5% higher. Akebia Therapeutics (AKBA
Express News | Stoke Therapeutics Prices Upsized $125M Public Offering Of 5,555,557 Common Shares At $13.50/Share
Stoke Therapeutics Announces Pricing of Upsized $125M Public Offering
Stoke Therapeutics Announces Pricing of Upsized $125M Public Offering
Understanding Stoke Therapeutics (STOK) Stock's Current Market Upturn
Stoke Therapeutics, Inc. (NASDAQ: STOK) is presently experiencing a significant surge of 45.36% in the US stock market, attaining a valuation of $14.96. This upswing in the current market session is directly correlated with a strategic move in equity disclosed by the company. As part of its underwritten public offering, Stoke Therapeutics (STOK) plans to ...
No Data
Jaguar8 : Oh wow
Jaguar8 : Good morning brother!
TrytosaveabitOP Jaguar8: Good morning my man!
TrytosaveabitOP Jaguar8: I was thinking it was going to be like 8/9 dollars! Hehehe
Jaguar8 : Only had 1.5hrs sleep
View more comments...